Skip to content

HSV still shed by HAART-treated patients, HSV suppressive therapy still needed

UK ramps up global AIDS funding, doubles Global Fund cash

Botswana: more testing, but men still reluctant

Prostate cancer more common in older HIV-positive men

Four days of Combivir reduces risk of nevirapine resistance from PMTCT treatment

Fluconazole doubles nevirapine levels, greatly increasing risk of liver toxicity

Heterosexual anal sex and first sexual exposure associated with high rates of HIV transmission in African youth

Nevirapine liver toxicity associated with CD4 percentage over 25% and genetic factors, rash alone with genetic factors only

Isoniazid prophylaxis halves risk of death for children with HIV in South Africa